BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21340680)

  • 1. Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes.
    Guthrie CR; Kraemer BC
    J Mol Neurosci; 2011 Sep; 45(1):32-41. PubMed ID: 21340680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of the oncoprotein v-ErbA to aggresomes.
    Bondzi C; Brunner AM; Munyikwa MR; Connor CD; Simmons AN; Stephens SL; Belt PA; Roggero VR; Mavinakere MS; Hinton SD; Allison LA
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):196-212. PubMed ID: 21075170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding with histone deacetylase 6 mediates the reversible recruitment of parkin to the centrosome.
    Jiang Q; Ren Y; Feng J
    J Neurosci; 2008 Nov; 28(48):12993-3002. PubMed ID: 19036992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.
    Yu Q; Zhang H; Li Y; Liu C; Wang S; Liao X
    Mol Neurobiol; 2018 May; 55(5):3812-3821. PubMed ID: 28540657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 6 interacts with the microtubule-associated protein tau.
    Ding H; Dolan PJ; Johnson GV
    J Neurochem; 2008 Sep; 106(5):2119-30. PubMed ID: 18636984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.
    Kawaguchi Y; Kovacs JJ; McLaurin A; Vance JM; Ito A; Yao TP
    Cell; 2003 Dec; 115(6):727-38. PubMed ID: 14675537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes.
    Johnston JA; Illing ME; Kopito RR
    Cell Motil Cytoskeleton; 2002 Sep; 53(1):26-38. PubMed ID: 12211113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.
    Richter-Landsberg C; Leyk J
    Acta Neuropathol; 2013 Dec; 126(6):793-807. PubMed ID: 23912309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy.
    Chiba Y; Takei S; Kawamura N; Kawaguchi Y; Sasaki K; Hasegawa-Ishii S; Furukawa A; Hosokawa M; Shimada A
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):559-71. PubMed ID: 22013984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.
    Hao R; Nanduri P; Rao Y; Panichelli RS; Ito A; Yoshida M; Yao TP
    Mol Cell; 2013 Sep; 51(6):819-28. PubMed ID: 24035499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
    Kalveram B; Schmidtke G; Groettrup M
    J Cell Sci; 2008 Dec; 121(Pt 24):4079-88. PubMed ID: 19033385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggresomes: a cellular response to misfolded proteins.
    Johnston JA; Ward CL; Kopito RR
    J Cell Biol; 1998 Dec; 143(7):1883-98. PubMed ID: 9864362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role for CHIP in the aggresome pathway.
    Sha Y; Pandit L; Zeng S; Eissa NT
    Mol Cell Biol; 2009 Jan; 29(1):116-28. PubMed ID: 18955503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation.
    Cook C; Gendron TF; Scheffel K; Carlomagno Y; Dunmore J; DeTure M; Petrucelli L
    Hum Mol Genet; 2012 Jul; 21(13):2936-45. PubMed ID: 22492994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.
    Burnett BG; Pittman RN
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4330-5. PubMed ID: 15767577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation.
    Song C; Xiao Z; Nagashima K; Li CC; Lockett SJ; Dai RM; Cho EH; Conrads TP; Veenstra TD; Colburn NH; Wang Q; Wang JM
    Toxicol Appl Pharmacol; 2008 May; 228(3):351-63. PubMed ID: 18261755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma.
    Hideshima T; Bradner JE; Wong J; Chauhan D; Richardson P; Schreiber SL; Anderson KC
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8567-72. PubMed ID: 15937109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification and significance of a novel degradation system for polyglutamine aggregates].
    Iwata A
    Rinsho Shinkeigaku; 2013; 53(1):1-8. PubMed ID: 23328059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.